X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2667) 2667
Book / eBook (9) 9
Book Chapter (7) 7
Conference Proceeding (4) 4
Book Review (1) 1
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1772) 1772
index medicus (1622) 1622
animals (1375) 1375
male (993) 993
female (599) 599
pharmacology & pharmacy (571) 571
platelet aggregation inhibitors - therapeutic use (523) 523
clopidogrel (510) 510
purinergic p2y receptor antagonists - therapeutic use (468) 468
adenosine - analogs & derivatives (466) 466
rats (463) 463
ticlopidine - analogs & derivatives (454) 454
adenosine (432) 432
middle aged (370) 370
mice (346) 346
neurosciences (337) 337
cardiac & cardiovascular systems (329) 329
ticlopidine - therapeutic use (326) 326
aged (323) 323
atp (315) 315
treatment outcome (307) 307
adenosine - therapeutic use (298) 298
percutaneous coronary intervention (289) 289
ticagrelor (284) 284
adenosine - pharmacology (281) 281
prasugrel (267) 267
purinergic p2 receptor antagonists (259) 259
dose-response relationship, drug (257) 257
acute coronary syndromes (255) 255
inflammation (246) 246
platelet aggregation inhibitors - adverse effects (243) 243
aspirin (231) 231
acute coronary syndrome - drug therapy (217) 217
activation (215) 215
platelet aggregation inhibitors - pharmacology (213) 213
purinergic p2y receptor antagonists - adverse effects (213) 213
prasugrel hydrochloride (212) 212
blood platelets - drug effects (211) 211
analysis (208) 208
adenosine triphosphate - pharmacology (206) 206
cell biology (205) 205
platelet aggregation - drug effects (205) 205
receptors (192) 192
platelet aggregation inhibitors - administration & dosage (189) 189
rats, sprague-dawley (188) 188
inhibition (186) 186
receptors, purinergic p2 - metabolism (186) 186
hematology (184) 184
receptors, purinergic p1 - metabolism (184) 184
aspirin - therapeutic use (181) 181
peripheral vascular disease (181) 181
abridged index medicus (180) 180
care and treatment (178) 178
physiology (176) 176
research (175) 175
purinergic p2y receptor antagonists - administration & dosage (174) 174
adult (171) 171
risk factors (170) 170
time factors (170) 170
adenosine triphosphate - metabolism (167) 167
antiplatelet therapy (167) 167
drug therapy, combination (166) 166
purinergic p1 receptor antagonists (165) 165
biochemistry & molecular biology (162) 162
in vitro techniques (162) 162
purinergic p2y receptor antagonists - pharmacology (161) 161
disease models, animal (160) 160
purinergic receptors (159) 159
signal transduction (159) 159
blood platelets - metabolism (158) 158
purinergic p1 receptor agonists (154) 154
cells, cultured (152) 152
piperazines - therapeutic use (151) 151
cardiovascular (150) 150
drug therapy (150) 150
biomedicine (149) 149
thiophenes - therapeutic use (149) 149
thrombosis (149) 149
acute coronary syndrome (148) 148
blood platelets (145) 145
physiological aspects (145) 145
pharmacology/toxicology (144) 144
cardiology (143) 143
extracellular atp (143) 143
rats, wistar (143) 143
coronary heart disease (141) 141
hemorrhage - chemically induced (137) 137
receptors, purinergic p2x7 - metabolism (136) 136
expression (133) 133
rodents (133) 133
health aspects (131) 131
medicine & public health (130) 130
cardiac patients (129) 129
adenosine - metabolism (128) 128
mice, inbred c57bl (126) 126
pharmacology (126) 126
receptors, purinergic p1 - physiology (125) 125
heart attacks (124) 124
ticlopidine - adverse effects (123) 123
p2x receptor (122) 122
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2646) 2646
Russian (11) 11
German (10) 10
French (9) 9
Japanese (7) 7
Hungarian (3) 3
Polish (3) 3
Spanish (2) 2
Turkish (2) 2
Czech (1) 1
Dutch (1) 1
Portuguese (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 5, pp. 611 - 621
Mortality and morbidity in acute coronary syndromes (ACSs), caused principally by plaque erosion or rupture leading to thrombus formation and myocardial ischemia, have been reduced by a combination of antithrombotic agents... 
Cardiovascular | WORKING GROUP | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTITHROMBOTIC THERAPY | DOUBLE-BLIND | ASSOCIATION TASK-FORCE | EUROPEAN-SOCIETY | ELEVATION MYOCARDIAL-INFARCTION | CONSENSUS DOCUMENT | PLATELET REACTIVITY | ATRIAL-FIBRILLATION | UNFRACTIONATED HEPARIN | Recombinant Proteins - therapeutic use | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Hirudins | Humans | Heparin - therapeutic use | Enoxaparin - therapeutic use | Tyrosine - analogs & derivatives | Receptors, Thrombin - antagonists & inhibitors | Warfarin - therapeutic use | Tyrosine - therapeutic use | Adenosine - therapeutic use | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Purinergic P2Y Receptor Antagonists - therapeutic use | Pyridines - therapeutic use | Polysaccharides - therapeutic use | Anticoagulants - therapeutic use | Piperazines - therapeutic use | Adenosine Monophosphate - therapeutic use | Lactones - therapeutic use | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Acute Coronary Syndrome - drug therapy | Adenosine - analogs & derivatives | Adenosine Monophosphate - analogs & derivatives | Peptide Fragments - therapeutic use | Peptides - therapeutic use | Aspirin | Glycosaminoglycans | Atrial fibrillation | Mortality | Thrombin | Anticoagulants (Medicine) | Health aspects | Drug approval | Coronary heart disease | Heart attacks | Acute coronary syndromes | Drug therapy | Clinical outcomes
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2014, Volume 12, Issue 2, pp. 187 - 195
.... Several new anticoagulants and antiplatelet agents recently were approved for use. Gastroenterologists may be unfamiliar with the mechanism of action, indications for use, and pharmacokinetics of these newer drugs... 
Gastroenterology and Hepatology | Anticoagulants/Administration and Dosage | Drug Administration Schedule | Thrombosis/Drug Therapy | Endoscopy | Drug Monitoring | Gastrointestinal | Atrial Fibrillation | Atrial fibrillation | Drug monitoring | Anticoagulants/Administration and dosage | Thrombosis/Drug therapy | Drug administration schedule | COLLEGE-OF-CARDIOLOGY | PERIOPERATIVE HEMOSTASIS | AMERICAN-HEART-ASSOCIATION | EUROPEAN-SOCIETY | ATRIAL-FIBRILLATION | WORKING GROUP | DABIGATRAN ETEXILATE | TASK-FORCE | ORAL ANTICOAGULANTS | POSITION PAPER | GASTROENTEROLOGY & HEPATOLOGY | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Proton Pump Inhibitors - pharmacology | Anticoagulants - administration & dosage | Ticlopidine - pharmacology | Ticlopidine - therapeutic use | Humans | Dabigatran | Drug Interactions | Benzimidazoles - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Polysaccharides - administration & dosage | Platelet Aggregation Inhibitors - pharmacokinetics | beta-Alanine - analogs & derivatives | Purinergic P2Y Receptor Antagonists - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Purinergic P2Y Receptor Antagonists - pharmacology | beta-Alanine - administration & dosage | Cholangiopancreatography, Endoscopic Retrograde | Thiophenes - pharmacology | Piperazines - therapeutic use | Anticoagulants - adverse effects | Proton Pump Inhibitors - therapeutic use | Piperazines - pharmacology | Ticlopidine - analogs & derivatives | Gastrointestinal Hemorrhage - chemically induced | Blood Coagulation Factors - therapeutic use | Anticoagulants - pharmacokinetics | Anticoagulants (Medicine)
Journal Article
Neuropharmacology, ISSN 0028-3908, 2016, Volume 104, pp. 31 - 49
...), P2Y and P2X receptors. We present a selection of the most commonly used agents to study purines in the nervous system... 
Nucleosides | GPCR | Agonists | Antagonists | Nucleotides | Ion channel | ATP | PROTEIN-COUPLED RECEPTORS | ALLOSTERIC MODULATION | NEUROSCIENCES | NEUROPATHIC PAIN | NUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE | IN-VIVO | ION-CHANNEL | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | PURINERGIC RECEPTOR | P2Y RECEPTOR | STRUCTURE-BASED DESIGN | Purinergic P1 Receptor Agonists - chemistry | Receptors, Purinergic P2Y - chemistry | Receptors, Purinergic P2X - chemistry | Humans | Purinergic P1 Receptor Agonists - pharmacology | Receptors, Purinergic P2Y - metabolism | Purinergic P1 Receptor Antagonists - therapeutic use | Purinergic P2Y Receptor Agonists - chemistry | Purinergic P2Y Receptor Agonists - therapeutic use | Structure-Activity Relationship | Purinergic P1 Receptor Agonists - therapeutic use | Chemistry, Pharmaceutical | Purinergic P1 Receptor Antagonists - pharmacology | Purinergic P2Y Receptor Agonists - pharmacology | Receptors, Purinergic P1 - chemistry | Animals | Purinergic Agents - chemistry | Purinergic Agents - therapeutic use | Receptors, Purinergic P2X - metabolism | Receptors, Purinergic P1 - metabolism | Purinergic Agents - pharmacology | Purinergic P1 Receptor Antagonists - chemistry | Prevention | Brain | Purines | Enzymes | Injuries | Chronic pain | Cancer | antagonists | nucleosides | agonists | ion channel | nucleotides
Journal Article
European heart journal, ISSN 0195-668X, 2016, Volume 37, Issue 3, pp. 267 - +
Cangrelor | Angioplasty | Anticoagulation | Bivalirudin | Nitrates | Rhythm monitoring | Dabigatran | Platelet inhibition | Stent | European society of cardiology | Guidelines | Recommendations | Rivaroxaban | Vorapaxar | Apixaban | Fondaparinux | Ticagrelor | Revascularization | Aspirin | Acute cardiac care | Unstable angina | Enoxaparin | Myocardial ischaemia | Beta-blockers | High-sensitivity troponin | Statin | Atherothrombosis | Glycoprotein IIb/IIIa inhibitors | Prasugrel | Early invasive strategy | Clopidogrel | Non-ST-elevation myocardial infarction | Bypass surgery | Chest pain unit | Diabetes | Heparin | Acute coronary syndromes | CARDIAC & CARDIOVASCULAR SYSTEMS | AMERICAN-HEART-ASSOCIATION | MOLECULAR-WEIGHT HEPARIN | ACUTE MYOCARDIAL-INFARCTION | ARTERY-BYPASS SURGERY | DUAL-ANTIPLATELET THERAPY | BARE-METAL STENTS | ACUTE CHEST-PAIN | European Society of Cardiology | SENSITIVITY CARDIAC TROPONIN | DRUG-ELUTING STENTS | Biomarkers - metabolism | Risk Assessment - methods | Diagnosis, Differential | Physical Examination - methods | Humans | Anticoagulants - therapeutic use | Hemorrhage - prevention & control | Long-Term Care | Angina Pectoris - etiology | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Cardiotonic Agents - therapeutic use | Algorithms | Coronary Angiography - methods | Percutaneous Coronary Intervention - methods | Acute Coronary Syndrome - diagnosis | Electrocardiography | Non-ST Elevated Myocardial Infarction - therapy | Acute Coronary Syndrome - therapy | Platelet Aggregation Inhibitors - therapeutic use | Non-ST Elevated Myocardial Infarction - diagnosis | Purinergic P2Y Receptor Antagonists - therapeutic use | Anticoagulants | Risk Assessment | Angina Pectoris | Platelet Glycoprotein GPIIb-IIIa Complex | Hemorrhage | Cardiotonic Agents | Life Sciences | Coronary Angiography | Human health and pathology | Non-ST Elevated Myocardial Infarction | Platelet Aggregation Inhibitors | Biomarkers | Physical Examination | Purinergic P2Y Receptor Antagonists | Percutaneous Coronary Intervention | Cardiology and cardiovascular system | Acute Coronary Syndrome
Journal Article